bpc-157 fda category 2 compounding Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for BPC-157 FDA Approval Status 2026:
BPC 157 FDA Approval Status 2026: Clinical Trials Peptides, ProRx, and the Government shutdown : r BigEasyWeightLoss The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like Industry Update: Interim 503A and 503B Bulks Lists New Revisions
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


